WebMay 28, 2024 · Granisetron extended-release subcutaneous injection (GERSC) is a unique formulation of granisetron for prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV). Limited data are available regarding the impact of GERSC on cost of UHs compared to other antiemetics. WebNov 12, 2024 · SUSTOL ® Net Product Sales: Net product sales of SUSTOL (granisetron) extended-release injection for the three and twelve months ended December 31, 2024 were $0.3 million and $0.8 million, respectively, compared to $0.5 million and $13.8 million for the same periods in 2024.
Granisetron Extended-Release Injection Information
WebDec 18, 2024 · Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial. Support Care Cancer. Epub 2014 … WebGranisetron extended-release injection has an extended half-life and should not be administered at less than 1-week intervals; g Emerging data in clinical practice suggest dexamethasone doses may be individualized. Higher doses may be considered, especially when an NK 1 RA is not given concomitantly. cineflix jk taguatinga
Sustol® (granisetron extended-release) - Magellan Provider
WebMar 2, 2024 · FDA Approved: Yes (First approved August 9, 2016) Brand name: Sustol. Generic name: granisetron. Dosage form: Extended-Release Injection. Company: Heron Therapeutics, Inc. Treatment for: Nausea/Vomiting, Chemotherapy Induced. Sustol (granisetron) is a long-acting 5-HT3 antagonist indicated for the prevention of … WebJun 19, 2024 · SubQ (extended-release injection): Remove extended-release injection kit from refrigeration at least 60 minutes prior to administration. Allow the syringe and all … WebAug 18, 2016 · Palliative and supportive care. Heron Therapeutics, Inc. announced on 10 August 2016 that the US Food and Drug Administration (FDA) has approved extended-release granisetron injection (SUSTOL®), a serotonin-3 (5-HT3) receptor antagonist indicated in combination with other antiemetics in adults for the prevention of acute and … cineflix led projector